Namita Thapar: Executive director of Emcure Pharmaceuticals, India’s Market Leader in Pharmaceutics
Namita Thapar is the executive director of Emcure Pharmaceuticals and a successful Indian women entrepreneur.
She has been instrumental in the growth and development of the company and has helped it become one of the leading pharmaceutical companies in India.
In this success story of Indian women entrepreneur, we will explore the success story of Namita Thapar and how she has been able to achieve such success.
From her early days in the industry to her current role at Emcure, we will take a look at how she has made a name for herself in the business world.
Early Life and Education
Namita Thapar was born in traditional Gujarati family on 21 March 1977 in Pune, India. She finished her schooling from Symbiosis High School.
She did her graduation from Pune University in Commerce. After completing her studies, she worked for a short while as a lecturer before joining Emcure Pharmaceuticals as a trainee chemist. Namita Thapar’s husband name is Vikas Thapar. They have two sons, Jai and Vir.
Under her leadership, Emcure has grown to become one of the leading Indian pharmaceutical companies with a turnover of Rs. 5,500 crore.
Thapar is also an active angel investor and has invested in startups such as mPhasis, Medi Assist, Portea Medical, Healthians and Grow Fit.
In 2017, she was conferred the ‘Entrepreneur of the Year’ award by The Indus Entrepreneurs (TiE) Delhi-NCR chapter.
Entrepreneurial Journey
Namita Thapar, Shark Tank India Judge is a successful Indian entrepreneur who began her career in the pharmaceutical industry.
She started her journey with Emcure as an executive director and rose through the ranks to become the executive director of the company. She worked in the field of marketing & finance in different companies.
She has managed multifaceted portfolios in marketing, finance, and HR. She oversees more than 5,000 medical representatives across India, contributing over $1 billion in sales. She also serves on the boards of Finolex Cables and Fuqua School of Business.
Emcure is now a leading player in the Indian pharmaceutical market with a turnover of over Rs 2,500 crore. The company has around 8,000 employees and has a presence in over 80 countries.
Thapar has been honoured with several awards, including the Ernst & Young Entrepreneur of the Year Award.
Emcure Pharmaceuticals, The Growing Indian Pharmaceutical Company
In the early 1980s, Namita Thapar was working as a medical representative for a foreign pharmaceutical company in India.
She was often frustrated by the company’s lack of focus on the Indian market and its lack of understanding of Indian customers. She joined Emcure Pharmaceuticals, as an executive director.
Emcure focused on manufacturing and marketing generic drugs, which are cheaper versions of brand-name drugs that have lost patent protection.
Thapar saw an opportunity in the Indian market for these drugs, as many patients could not afford the high cost of brand-name drugs. Emcure quickly became one of the leading suppliers of generic drugs in India.
Read also: Sugar Cosmetics: How This 100% Vegan, Cruelty-Free Skincare Line Became a Success
The company has now grown to over 9,000 employees and is one of the country’s largest pharmaceutical companies. It has a turnover of Rs. 5,500 crore (approximately $800 million).
Thapar has been recognized as one of India’s most successful Indian Businesswomen and women entrepreneurs.
She was named “Businesswoman of the Year” by Business Today magazine and “Entrepreneur of the Year” by Ernst & Young.
Namita Thapar’s Career
Namita Thapar is Shark Tank India Judge and the executive director of Emcure Pharmaceuticals, one of India’s leading pharmaceutical companies.
She is also a successful entrepreneur, with a number of businesses to her name. She quickly rose through the ranks, becoming managing director of the company within a few years.
Under her leadership, Emcure has become one of the most successful pharmaceutical companies in India. The company has also been recognised as one of the best employers in the country.
Thapar is a strong advocate for women’s empowerment, and has been honoured by the Indian government for her work in this area. She is an inspiration to many young women who are looking to start their own businesses.
Namita Thaper as a judge in Shark Tank India Reality Show
She recently appeared in top-rated business reality show, Shark Tank India on Television as one of the investors and famous for her dialogue, “Ye meri expertise Nahi hai, toh I am out.” in Shark Tank reality show.
Namita Thaper has become a popular name among the masses ever since she appeared as a judge on the most popular business reality Television show Shark Tank India. Namita invested more than ₹10 crores in 25 startups in the Shark Tank India reality show’s first season.
Namita Thapar net worth:
Executive director Emcure Pharmaceuticals and successful Indian women entrepreneur, Namita Thapar’s net worth is close to a whopping Rs 600 Crore.
Read also: Aman Gupta, The success story of the co-founder of boAt
The Bottom Line
Namita Thapar is a prime example of what hard work and dedication can lead to. Through her journey as the executive director of Emcure Pharmaceuticals, she has faced many challenges but has always come out on top.
Namita Thapar is a role model for women entrepreneur and exemplifies what can be achieved with determinationa and hard work. Namita is a true inspiration, and her success story is a testament to the power of women in business.
Her story is truly inspiring and is a great reminder that anything is possible if you set your mind to it. Thank you for reading and we hope Namita Thapar’s success story has motivated you to pursue your own dreams.
Are you an
Entrepreneur or Startup? Do you have a Success Story to Share? SugerMint would like to share your success story. We cover entrepreneur Stories, Startup News, Women entrepreneur stories, and Startup stories
|
Read more Success story of India entrepreneurs & startups at SugerMint. Follow us on Twitter, Instagram, Facebook, LinkedIn